Abingworth
Graham joined Abingworth’s London office in January 2022 working with the transatlantic team in evaluating new investment opportunities and supporting existing portfolio companies in a therapeutic area-agnostic approach.
Previously, Graham was Founder & Managing Director at healthcare-focused tech startup techspert.io, where he built significant experience in scaling early-stage ventures and navigating the challenges through development. Before & alongside this, Graham worked actively in the investment teams of JJDC and Seroba Life Sciences, developing broad investment theses through new opportunity evaluation and detailed therapeutic landscape analyses.
Graham holds a Ph.D. in Medical Biology from the University of Cambridge, an MRes in Translational Cancer Medicine from King’s College London, a BA in Genetics from Trinity College Dublin, and an MBA from the Quantic School of Business & Technology.
This person is not in the org chart
This person is not in any offices
Abingworth
1 followers
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life sciences sectors. Supporting its portfolio companies with a team of 25 at offices in London, Menlo Park, and Boston, Abingworth has invested in 151 life science companies, completed 65 IPOs and 42 mergers and acquisitions.